LONDON, UK / ACCESS Newswire / September 29, 2026 / Nanomerics Ltd, a clinical-stage speciality pharmaceutical company, today announced the…
79 true stories of hope, healing and breakthrough from veterans, celebrities, CEOs and everyday seekers who journeyed with plant medicine…
Proprietary intranasal delivery technology being developed initially for GLP-1 receptor agonistsLOUGHBOROUGH, United Kingdom, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Landmark…
SHELTON, CT / ACCESS Newswire / September 28, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader…
Company highlights ongoing clinical developments in traumatic brain injury (TBI) therapeutics and non-invasive cancer screening, sparking key vendor collaboration discussions.…
Nicole Ferrara, PhD, will investigate how social deprivation alters amygdala development and social behavior during adolescenceNORTH CHICAGO, Ill., Sept. 24,…
SAN DIEGO, Sept. 24, 2026 /PRNewswire/ -- Recently, ACROBiosystems unveiled its latest innovation portfolio—ACRO AIx, CHO-Direct and GlobalLifeShip cross border supply…
NORTH CANTON, Ohio, Sept. 24, 2026 /PRNewswire/ -- The Collegiate Inventors Competition®, an annual competition that has rewarded innovations, discoveries…
The Association aligns strategy, creative and media across brand and fundraising with Moore to accelerate mission impact.WASHINGTON, Sept. 24, 2026…
~ Submission to the UK MHRA for review marks critical step towards initiating a Phase 2 Study with CY200 ~…